Show
Sort by
-
Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects
-
Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases
-
Radiological sacroiliitis in Crohn's disease: A multicenter association study
-
CC-type chemokine receptor 5-Delta 32 mutation protects against primary sclerosing cholangitis
-
Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study
-
The TNF/Adam 17 system: Implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease
-
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease
-
The ideal management of Crohn's disease: Top down versus step up strategies, a randomized controlled trial
-
Pharmacogenetic analysis of OCTN and DLG5 polymorphisms shows further evidence for association of the OCTN TC risk haplotype with lower response to infliximab in Crohn's disease
-
Lactulose administration in healthy volunteers is associated with a reduced b-glucuronidase activity and an increase in fecal bifidobacteria